Patents by Inventor Stephen A. Goff

Stephen A. Goff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8115058
    Abstract: The present invention provides promoters from plants capable of driving gene expression in plant cells. The promoters vary in strength and in tissue specificity, and can be used to facilitate the development of transgenic plants in which tissue preferred expression, constitutive expression, and the strength of transgene expression is either more or less critical.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: February 14, 2012
    Assignee: Syngenta Participations AG
    Inventors: Paul Budworth, Todd Moughamer, Steven P. Briggs, Bret Cooper, Jane Glazebrook, Stephen A. Goff, Fumiaki Katagiri, Joel Kreps, Nicholas Provart, Darrell Ricke, Tong Zhu
  • Publication number: 20110225678
    Abstract: The present invention provides promoters from plants capable of driving gene expression in plant cells. The promoters vary in strength and in tissue specificity, and can be used to facilitate the development of transgenic plants in which tissue preferred expression, constitutive expression, and the strength of transgene expression is either more or less critical.
    Type: Application
    Filed: May 23, 2011
    Publication date: September 15, 2011
    Inventors: Paul Budworth, Todd Moughamer, Steven P. Briggs, Bret Cooper, Jane Glazebrook, Stephen A. Goff, Fumlaki Kataglri, Joel Kreps, Nicholas Provart, Darrell Ricke, Tong Zhu
  • Publication number: 20100275333
    Abstract: Abiotic stress responsive polynucleotides and polypeptides are disclosed. Also disclosed are vectors, expression cassettes, host cells, and plants containing such polynucleotides. Also provided are methods for using such polynucleotides and polypeptides, for example, to alter the responsiveness of a plant to abiotic stress.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 28, 2010
    Inventors: Joel Kreps, Steven P. Briggs, Stephen A. Goff, Fumiaki Katagiri, Todd Moughamer, Nicholas Provart, Darrell Ricke, Tong Zhu, Robert Dietrich, Bret Cooper
  • Patent number: 7777097
    Abstract: The invention relates to methods of producing plants with increased resistance to pathogen infection by expressing disease resistance genes in the plants and transgenic plants having enhanced pathogen resistance.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: August 17, 2010
    Assignee: Syngenta Participations AG
    Inventors: Jane Glazebrook, Steven P. Briggs, Bret Cooper, Stephen A. Goff, Todd Moughamer, Fumiyaki Katagiri, Joel Kreps, Nicholas Provart, Darrell Ricke, Tong Zhu
  • Patent number: 7550578
    Abstract: The present invention provides promoters from plants capable of driving gene expression in plant cells. The promoters vary in strength and in tissue specificity, and can be used to facilitate the development of transgenic plants in which tissue preferred expression, constitutive expression, and the strength of transgene expression is either more or less critical.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: June 23, 2009
    Assignee: Syngenta Participations AG
    Inventors: Paul Budworth, Todd Moughamer, Steven P. Briggs, Bret Cooper, Jane Glazebrook, Stephen A. Goff, Fumiaki Katagiri, Joel Kreps, Nicholas Provart, Darrell Ricke, Tong Zhu
  • Patent number: 7053195
    Abstract: The present invention relates to methods of replacing nucleotides in target nucleic acid sequences using DNA-LNA chimeras. The method of the present invention provides for replacing a first nucleotide in a target sequence by exposing the target sequence to a DNA-LNA heteropolymer and thereby replacing the first nucleotide with a second nucleotide. The invention also features the DNA-LNA chimeras themselves as well as methods of making them.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: May 30, 2006
    Assignee: Syngenta participatious AG
    Inventor: Stephen A. Goff
  • Patent number: 6939711
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5? regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3? termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5? regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3? termination region.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: September 6, 2005
    Assignee: Syngenta Investment Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Publication number: 20030135888
    Abstract: The invention provides a method to identify genes that are modulated by posttranscriptional gene silencing as well as regulatory elements and methods to modulate gene expression by posttranscriptional gene silencing.
    Type: Application
    Filed: September 26, 2002
    Publication date: July 17, 2003
    Inventors: Tong Zhu, Xun Wang, Hur-Song Chang, Steven P. Briggs, Bret Cooper, Jane Glazebrook, Stephen A. Goff, Fumiaki Katagiri, Joel Kreps, Todd Moughamer, Nicholas Provart, Darrell Ricke
  • Publication number: 20010022004
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3′ termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3′ termination region.
    Type: Application
    Filed: March 21, 2001
    Publication date: September 13, 2001
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 6147282
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: November 14, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 5880333
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: March 9, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 4758512
    Type: Grant
    Filed: March 6, 1984
    Date of Patent: July 19, 1988
    Assignee: President and Fellows of Harvard College
    Inventors: Alfred L. Goldberg, Stephen A. Goff, Lawrence P. Casson